2 results match your criteria: "Institute of Health Research (IDIS)[Affiliation]"
ACS Appl Mater Interfaces
December 2024
Colloids and Polymers Physics Group, Department of Applied Physics, Faculty of Physics and Institute of Materials (iMATUS) and Institute of Health Research (IDIS), University of Santiago de Compostela, 15782 Santiago de Compostela, Spain.
Current models for elastin-like recombinamer (ELR) design struggle to predict the effects of nonprotein fused materials on polypeptide conformation and temperature-responsive properties. To address this shortage, we investigated the novel functionalization of ELRs with cholesterol (CTA). We employed GROMACS computational molecular dynamic simulations complemented with experimental evidence to validate the predictions.
View Article and Find Full Text PDFPharmaceutics
June 2021
Clinical Pharmacology Group, Institute of Health Research (IDIS), Travesía da Choupana s/n, 15706 Santiago de Compostela, Spain.
Over the last two decades, pharmacogenetics and pharmacokinetics have been increasingly used in clinical practice in Psychiatry due to the high variability regarding response and side effects of antipsychotic drugs. Specifically, long-acting injectable (LAI) antipsychotics have different pharmacokinetic profile than oral formulations due to their sustained release characteristics. In addition, most of these drugs are metabolized by , whose interindividual genetic variability results in different metabolizer status and, consequently, into different plasma concentrations of the drugs.
View Article and Find Full Text PDF